Edition:
United States

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

56.40CHF
28 Apr 2017
Change (% chg)

CHF-0.30 (-0.53%)
Prev Close
CHF56.70
Open
CHF56.80
Day's High
CHF56.80
Day's Low
CHF55.85
Volume
80,683
Avg. Vol
132,264
52-wk High
CHF61.00
52-wk Low
CHF42.15

BION.S

Chart for BION.S

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.20
Market Cap(Mil.): CHF3,124.56
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.88

Financials

  BION.S Industry Sector
P/E (TTM): 4.03 58.40 30.08
EPS (TTM): 13.98 -- --
ROI: 26.77 -0.42 13.25
ROE: 26.77 5.87 14.41

BRIEF-BB Biotech posts Q1 net profit of 375 million Swiss francs

* Earned a bottom-line profit of 375 million Swiss francs ($375.45 million) in Q1 of 2017

Apr 21 2017

BRIEF-BB Biotech FY operating income down at CHF 9.5 mln

* FY operating income 9.5 million Swiss francs ($9.52 million)versus 697.9 million Swiss francs year ago Source text - http://bit.ly/2losLsW

Feb 17 2017

BRIEF-BB Biotech proposes dividend of CHF 2.75 per share

* Portfolio performs well in in the volatile fourth quarter of 2016

Jan 20 2017

BRIEF-BB Biotech FY 2016 result swings to loss of CHF 802 million

* Closed business year 2016 based on preliminary unaudited consolidated results with a loss of approximately 802 million Swiss francs (-$794.77 million) (653 million Swiss francs profit in previous year) Source text for Eikon: Further company coverage: ($1 = 1.0091 Swiss francs) (Gdynia Newsroom)

Jan 13 2017

More From Around the Web

Earnings vs. Estimates